The forecasted sales for blood and blood-forming organs medicines in Italy indicate a steady upward trend from 2024 to 2028. Starting at 4.13 billion USD in 2024, sales are projected to increase to 4.64 billion USD by 2028, reflecting a compound annual growth rate (CAGR) over five years. The persistent demand and slight growth illustrate a healthy market trajectory from the year 2023, which had established a foundation for these forecasts.
Future trends to watch for include:
- Innovations in blood-related therapies potentially expanding the market
- Regulatory changes impacting market dynamics
- Increasing focus on personalized medicine and biotechnological advancements
